medical intravenous IV drip

Key Takeaways

  • Regular monitoring, including John Cunningham virus (JCV) antibody testing and periodic MRI scans, is a standard part of long-term Tysabri treatment for MS.
  • Tysabri is available only through the TOUCH Prescribing Program, which builds ongoing safety checks into treatment between you, your neurologist, and your infusion provider.
  • Headache, fatigue, and infections are among the more common side effects reported in clinical studies of Tysabri.
  • Staying in close contact with your neurologist helps you and your care team spot and address any changes early.  
  • Smart Infusion Therapy Services supports long-term Tysabri treatment with trained nursing staff, monitoring during each visit, and detailed updates sent to your neurologist.

Schedule Now

Why Does Tysabri Require Ongoing Monitoring?

Tysabri, known by its chemical name natalizumab, is a well-studied treatment for relapsing forms of multiple sclerosis, and long-term safety monitoring has been part of how it is prescribed since it returned to the market in 2006, according to the Multiple Sclerosis Association of America. Because Tysabri affects how certain immune cells move through the body, people on long-term treatment are monitored for a rare but serious brain infection called progressive multifocal leukoencephalopathy, or PML.

That is why everyone who takes Tysabri must be enrolled in the TOUCH Prescribing Program, a safety program required by the FDA that keeps your neurologist, pharmacy, and infusion provider connected throughout treatment, according to the FDA-approved prescribing information on DailyMed.

What Does Long-Term Tysabri Treatment Involve?

Before you start Tysabri, you will be tested for JCV antibodies and will have a baseline brain MRI, which gives your care team a reference picture to compare against later scans. Once treatment is underway, Mayo Clinic explains that your doctor checks your progress at 3 months and 6 months after the first dose and then every 6 months. People who test negative for JCV antibodies are retested over time, and the European Medicines Agency recommends retesting about every 6 months.

Your risk of PML depends on three known factors: having JCV antibodies, using Tysabri for longer than two years, and having used immune-weakening medicines in the past. If your risk is higher, your neurologist may recommend more frequent MRI scans. The European Medicines Agency suggests considering scans every 3 to 6 months using shorter scan protocols for people at higher risk.

Tysabri can cause side effects, and they vary from person to person. The more common side effects reported in clinical studies include headache, fatigue, and infections such as upper respiratory or urinary tract infections, along with infusion-related reactions that are watched for during and after each visit.

What Do Patients Most Often Ask About Long-Term Safety?

People starting Tysabri often want to know:

  • How long can I safely stay on Tysabri?
  • What exactly is PML, and how will I know if my risk changes?
  • Which symptoms should prompt a call to my neurologist?

Your neurologist is the best person to answer the first two for your situation. For the third, any new or worsening neurological symptom, such as vision changes, weakness, or confusion, should be reported promptly, since it can be a sign of an MS relapse or a different issue that needs evaluation. This applies during treatment and for up to 6 months after stopping Tysabri. JCV antibody testing is not used to diagnose PML. According to the FDA, PML is diagnosed using symptoms, MRI findings, and testing for JC virus in spinal fluid. That is why JCV testing, scheduled MRIs, and regular neurologist visits work together rather than relying on any single check. 

Why Is It Important to Keep Your Neurologist Updated?

Long-term Tysabri treatment works best as a partnership between you, your neurologist, and your infusion team. Share any new symptoms, infections, or changes in your health at every visit, even ones that seem unrelated to MS. Keeping your JCV testing and MRI appointments on schedule, rather than skipping or postponing them, is one of the most direct ways to stay ahead of potential safety concerns.

What Happens at Each Infusion Visit?

At Smart Infusion Therapy Services, which provides IV therapy services for MS and other conditions, every Tysabri infusion is given by trained nurses who monitor you during the one-hour infusion and for a period afterward. For the first 12 infusions, you are observed for an additional hour once the infusion ends. After each visit, Smart Infusion sends a detailed note to your neurologist, so they have a clear, current picture of how treatment is going. You can learn more about neurology infusion services at Smart Infusion. 

Here is a general picture of the monitoring schedule. Your neurologist sets the exact timing for you.

Monitoring StepTypical Timing
Baseline brain MRI and JCV antibody testBefore starting Tysabri
Treatment review with your neurologistAt 3 and 6 months, then every 6 months
JCV antibody testing (if JCV negative)Often about every 6 months, with timing set by your neurologist
More frequent MRI scans (if PML risk is higher)May be considered every 3 to 6 months

Ready to Continue or Start Tysabri Care?

Long-term Tysabri treatment follows a clear monitoring schedule designed to help you and your neurologist catch changes early. Smart Infusion Therapy Services supports that process with trained infusion nurses, monitoring during every visit, and detailed communication with your neurologist.

To begin or continue Tysabri infusion therapy, request an appointment with Smart Infusion Therapy Services.

Frequently Asked Questions

Is Tysabri safe for long-term MS treatment?

Tysabri has been shown in clinical studies to reduce relapses in relapsing forms of MS, and its long-term safety is managed through a required monitoring program that includes JCV testing and periodic MRI scans. It also carries a boxed warning, the FDA's strongest type of warning, for PML. Talk with your neurologist about your individual risk factors. 

What are the most common Tysabri side effects?

The more common side effects reported in clinical studies include headache, fatigue, and infections such as upper respiratory or urinary tract infections. Infusion-related reactions are also watched for during and after each treatment.

Why does Tysabri require JCV antibody testing?

Your JCV antibody status helps your neurologist assess your risk of PML, a rare brain infection associated with natalizumab. If you test positive for JCV antibodies, your neurologist may monitor you more closely, depending on your other risk factors.

What should I do if I notice new symptoms while on Tysabri?

Report any new or worsening neurological symptoms, such as vision changes, weakness, or confusion, to your neurologist promptly so it can be properly evaluated. Keep reporting new symptoms for up to 6 months after stopping Tysabri.